Skip to main content

Published locations for Ofatumumab approved for extended treatment of CLL patients in complete or partial response

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Ofatumumab approved for extended treatment of CLL patients in complete or partial response

User login

  • Reset your password
  • /content/ofatumumab-approved-extended-treatment-cll-patients-complete-or-partial-response
  • /hematologynews/article/105883/cll/ofatumumab-approved-extended-treatment-cll-patients-complete-or
  • /oncologypractice/article/105883/cll/ofatumumab-approved-extended-treatment-cll-patients-complete-or
  • /hematology-oncology/article/105883/cll/ofatumumab-approved-extended-treatment-cll-patients-complete
  • /b-cell-lymphoma-icymi/article/105883/cll/ofatumumab-approved-extended-treatment-cll-patients